Digital Therapeutics (DTx) Market by Application (Prediabetes, Nutrition, Care, Diabetes, CVD, CNS, CRD, MSD, GI, Substance Abuse, Rehabilitation), Sales Channel (B2C, Patient, Caregiver, B2B, Providers, Payer, Employer, Pharma)

Growing incidence of preventable chronic diseases and the need to control healthcare costs are the key factors driving the growth of the digital therapeutics market

Growth in this market is mainly driven by the growing incidence of preventable chronic diseases, the need to control healthcare costs and rising investments in digital therapeutics. On the other hand, a lack of awareness and access to digital therapeutics programs in developing countries, resistance from traditional healthcare providers, and unstable payment models are challenging the growth of this market.

Treatment/care-related applications segment accounted for the largest share of the digital therapeutics market in 2019

Based on the application, the digital therapeutics market is segmented into preventive and treatment/care-related applications. Rising healthcare costs, the growing prevalence of chronic diseases, and the ability of digital therapeutics to provide cost-effective solutions are some factors responsible for driving the market for treatment/care-related digital therapeutics applications.

Diabetes segment is expected to dominate the market

Based on the type of treatment/care-related application, the digital therapeutics market is further segmented into diabetes, CNS disorders, chronic respiratory diseases, musculoskeletal disorders, cardiovascular diseases, smoking cessation, medication adherence, gastrointestinal disorders, substance use disorders & addiction management, rehabilitation & patient care, and other treatment/care-related applications. The diabetes segment accounted for the largest share of the digital therapeutics market. The large share of this segment is attributed to the growing prevalence of diabetes across the globe. In addition, government initiatives to reduce the burden of diabetes using digital health are responsible for the large share of this segment.

B2B segment is expected to grow at the highest CAGR during the forecast period.

Based on the sales channel, the digital therapeutics market is segmented into business-to-customer (B2C) and business-to-business (B2B). The B2B segment is the largest and fastest-growing segment of the digital therapeutics market. The high preference of pharmaceutical companies to integrate digital therapeutics with their drug products to offer adherence services is a key factor driving the growth of this segment. Furthermore, rising awareness among payers, employers, and providers about the benefits of digital therapeutics has also supported the market growth.

North America to be the largest and the fastest-growing regional market

North America, which comprises the US and Canada, forms the largest market for digital therapeutics. The US is home to a plethora of digital therapeutics start-ups. In addition, government initiatives to support technological advancements, improvements in the reimbursement structure for digital therapeutics, and the increasing investments in digital therapeutics are responsible for the high growth of digital therapeutics in North America.

The primary interviews conducted for this report can be categorized as follows:

By Company Type: Tier 1 (50%), Tier 2 (30%), and Tier 3 (20%)
By Designation: C-level (75%), D-level (15%), and Others (10%)
By Region: North America (70%), Europe (20%), APAC (7%), and the RoW (3%)

List of Companies Profiled in the Report

Noom (US)
Livongo Health (US)
Omada Health (US)
WellDoc (US)
Pear Therapeutics (US)
Proteus Digital Health (US)
Propeller Health (US)
Akili Interactive Labs (US)
Better Therapeutics (US)
Happify (US)
Kaia Health (Germany)
Mango Health (US)
Click Therapeutics (US)
Canary Health (US)
Wellthy Therapeutics (India)
Cognoa (US)
Ayogo Health (Canada)
Mindstrong Health (US)
2Morrow (US)
Ginger (US)

Research Coverage:

This report provides a study of the digital therapeutics market. It aims at estimating the size and future growth potential of the market across different segments, such as sales channel, application, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of revenue numbers for the overall digital therapeutics market and its subsegments. This report will also help stakeholders understand the competitive landscape, gain insights to position their business and make suitable go-to-market strategies. It will also enable stakeholders to gauge the pulse of the market and provide them with information on the key market drivers, restraints, challenges, and opportunities.

1 Introduction

1.1 Objectives Of The Study
1.2 Market Definition
1.2.1 Markets Covered
1.2.2 Years Considered For The Study
1.3 Currency
1.4 Limitations
1.5 Stakeholders
1.6 Limitations

2 Research Methodology

2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.1.1 Approach One: Revenue Mapping-Based Estimation
2.2.1.2 Approach Two: Buyer Adoption-Based Estimation
2.2.2 Top-Down Approach: Penetration Rate Based Market Size Estimation
2.2.3 Growth Forecast
2.3 Market Breakdown And Data Triangulation
2.4 Market Player Ranking
2.5 Assumptions For The Study

3 Executive Summary

4 Premium Insights

4.1 Digital Therapeutics Market Overview
4.2 Digital Therapeutics Market, By Sales Channel, 2020-2025
4.3 B2B Sales Channel Market Share, By Buyer & Region (2019)
4.4 Digital Therapeutics Market: Geographic Growth Opportunities

5 Market Overview

5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Incidence Of Preventable Chronic Diseases
5.2.1.2 Rising Focus On Preventive Healthcare
5.2.1.3 Need To Control Healthcare Costs
5.2.1.4 Significant Increase In Venture Capital Investments
5.2.1.5 Benefits Of Digital Therapeutics
5.2.1.5.1 Ability To Induce Behavioral Change
5.2.1.5.2 Improved Drug Adherence
5.2.1.5.3 Patient Convenience And User-Friendliness
5.2.2 Restraints
5.2.2.1 Patient Data Privacy Concerns
5.2.3 Opportunities
5.2.3.1 Emerging Markets
5.2.3.2 Large Undiagnosed And Untreated Population
5.2.3.3 Unexplored Therapeutic Applications
5.2.4 Challenges
5.2.4.1 Unstable Payment Models
5.2.4.2 Reluctance Among Patients To Adopt Digital Therapeutics
5.2.4.3 Lack Of Awareness And Access To Digital Therapeutics Programs In Developing Countries
5.2.4.4 Resistance From Traditional Healthcare Providers

6 Digital Therapeutics Market, By Sales Channel

6.1 Introduction
6.2 B2B
6.2.1 Payers
6.2.1.1 Payers Hold The Highest Share Of The Market, By B2B Sales
6.2.2 Employers
6.2.2.1 Importance Of Employee Health Management Is Propelling The Adoption Of Digital Therapeutics Among Employers
6.2.3 Pharmaceutical Companies
6.2.3.1 Cross-Industry Collaboration Between Digital Therapeutics Start-Ups And Pharmaceutical Companies Will Drive Market Growth
6.2.4 Providers
6.2.4.1 Potential For Better Patient Management And Cost-Reductions Are Driving Demand For Digital Therapeutics Among Providers
6.2.5 Other Buyers
6.3 B2C
6.3.1 Caregivers
6.3.1.1 Ease Of Managing Health Conditions Has Driven Demand For Solutions Among Caregivers
6.3.2 Patients
6.3.2.1 Awareness About Preventive Health Among Patients Will Drive The Growth Of This Segment

7 Digital Therapeutics Market, By Application

7.1 Introduction
7.2 Treatment/Care-Related Applications
7.2.1 Diabetes
7.2.1.1 Growing Prevalence Of Diabetes Drives Market Growth
7.2.2 Central Nervous System Disorders
7.2.2.1 Potential Benefits Of Digital Therapeutics In Cns Disorder Management Have Driven The Development Of Solutions
7.2.3 Smoking Cessation
7.2.3.1 Focus On Providing Clinically Validated, Effective Mobile Applications To Help Quit Smoking Drives Market Growth
7.2.4 Chronic Respiratory Diseases
7.2.4.1 Growing Prevalence Of Copd And Asthma Is Responsible For Market Growth In This Segment
7.2.5 Musculoskeletal Disorders
7.2.5.1 Potential Of Digital Therapeutics In Better Pain Management To Drive The Adoption Of These Solutions Among End Users
7.2.6 Cardiovascular Diseases
7.2.6.1 Increasing Care Cost Of Cvd To Drive The Need For Digital Therapeutics Solutions
7.2.7 Medication Adherence
7.2.7.1 Need To Drive Medication Adherence Rates Have Propelled The Demand For Effective Solutions
7.2.8 Gastrointestinal Disorders
7.2.8.1 Availability Of Mobile Applications For The Management Of Gi Conditions To Drive The Market Growth
7.2.9 Rehabilitation & Patient Care
7.2.9.1 Benefits Of Digital Therapeutics Have Induced Startups To Develop Platforms For Patient Care
7.2.10 Substance Use Disorders & Addiction Management
7.2.10.1 Potential To Improve The Efficiency Of Behavioral Interventions Are Encouraging Market Growth
7.2.11 Other Treatment/Care-Related Applications
7.3 Preventive Applications
7.3.1 Prediabetes
7.3.1.1 Influx Of Startups To Provide Effective Prevention Against Prediabetes Drives The Growth Of This Segment
7.3.2 Obesity
7.3.2.1 Availability Of Cost-Effective Solutions For Obesity Management Propels The Growth Of This Segment
7.3.3 Nutrition
7.3.3.1 Importance Of Nutrition In Preventing A Wide Range Of Ailments Has Driven Demand For Digital Therapeutic Solutions
7.3.4 Lifestyle Management
7.3.4.1 Ability Of Digital Therapeutics Solutions To Induce Positive Behavioral Changes Has Contributed To Rise In Demand
7.3.5 Other Preventive Applications

8 Digital Therapeutics Market, By Region

8.1 Introduction
8.2 North America
8.2.1 US
8.2.1.1 Major Digital Therapeutics Start-Ups Are Based Out Of The Us, Which Has Greatly Supported Access To Solutions
8.2.2 Canada
8.2.2.1 Efforts Are Being Taken By The Canadian Government To Support Digital Therapeutics
8.3 Europe
8.3.1 Germany
8.3.1.1 Germany Accounted For The Largest Share Of The Digital Therapeutics Market In Europe
8.3.2 UK
8.3.2.1 Well-Established Healthcare System And Government Support Will Propel The Growth Of The Market
8.3.3 France
8.3.3.1 Growing Healthcare Expenditure And Favorable Health Insurance System To Support Market Growth In France
8.3.4 Spain
8.3.4.1 Initiatives By Emerging Digital Therapeutics Startups Are Supporting Market Growth
8.3.5 Italy
8.3.5.1 Need For Alternative And Effective Treatment To Drive The Market Growth In Coming Years
8.3.6 Rest Of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.1.1 Rising Diabetes Incidence And Collaborations Between Stakeholders Are Indicators Of Market Growth In Japan
8.4.2 China
8.4.2.1 Growing Geriatric Population And Incidence Of Chronic Conditions Will Drive Demand For Digital Therapeutics In China
8.4.3 India
8.4.3.1 Rising Chronic Disease Incidence And The Need For Better Disease Management Drive Market Growth
8.4.4 Rest Of Apac
8.5 Rest Of The World
8.5.1 Rising Burden On Healthcare Systems Drives Demand For Alternative, Cost-Effective Therapies In The Row

9 Competitive Landscape

9.1 Overview
9.2 Market Ranking Analysis, 2019
9.3 Competitive Leadership Mapping
9.3.1 Visionary Leaders
9.3.2 Dynamic Differentiators
9.3.3 Innovators
9.3.4 Emerging Companies
9.4 Competitive Situation And Trends
9.4.1 Product Launches
9.4.2 Expansions
9.4.3 Partnerships, Agreements & Collaborations

10 Company Profiles

10.1 Noom
10.1.1 Business Overview
10.1.2 Products Offered
10.1.3 Recent Developments
10.2 Livongo Health
10.2.1 Business Overview
10.2.2 Products Offered
10.2.3 Recent Developments
10.3 Omada Health
10.3.1 Business Overview
10.3.2 Products Offered
10.3.3 Recent Developments
10.4 Proteus Digital Health
10.4.1 Business Overview
10.4.2 Products Offered
10.4.3 Recent Developments
10.5 Welldoc
10.5.1 Business Overview
10.5.2 Products Offered
10.5.3 Recent Developments
10.6 Ginger
10.6.1 Business Overview
10.6.2 Products Offered
10.7 Propeller Health
10.7.1 Business Overview
10.7.2 Products Offered
10.8 2Morrow
10.8.1 Business Overview
10.8.2 Products Offered
10.8.3 Recent Developments
10.9 Canary Health
10.9.1 Business Overview
10.9.2 Products Offered
10.9.3 Recent Developments
10.10 Mango Health Inc.
10.10.1 Business Overview
10.10.2 Products Offered
10.10.3 Recent Developments
10.11 Click Therapeutics
10.11.1 Business Overview
10.11.2 Products Offered
10.11.3 Recent Developments
10.12 Pear Therapeutics
10.12.1 Business Overview
10.12.2 Products & Services Offered
10.12.3 Recent Developments
10.13 Akili Interactive Labs
10.13.1 Business Overview
10.13.2 Products Offered
10.13.3 Recent Developments
10.14 Wellthy Therapeutics
10.14.1 Business Overview
10.14.2 Products Offered
10.14.3 Recent Developments
10.15 Cognoa
10.15.1 Business Overview
10.15.2 Products Offered
10.15.3 Recent Developments
10.16 Happify
10.16.1 Business Overview
10.16.2 Products Offered
10.16.3 Recent Developments
10.17 Kaia Health
10.17.1 Business Overview
10.17.2 Products Offered
10.18 Ayogo Health
10.18.1 Business Overview
10.18.2 Products Offered
10.18.3 Recent Developments
10.19 Better Therapeutics
10.19.1 Business Overview
10.19.2 Products Offered
10.20 Mindstrong Health
10.20.1 Business Overview
10.20.2 Products Offered

11 Appendix

11.1 Knowledge Store: Subscription Portal
11.2 Available Customizations
11.3 Related Reports
11.4 Author Details

List of Tables

Table 1 Factor Analysis
Table 2 Digital Therapeutics Market, By Sales Channel, 2018-2025 (USD Million)
Table 3 Digital Therapeutics Market For B2B Sales Channel, By Buyer, 2018-2025 (USD Million)
Table 4 Digital Therapeutics Market For B2B Sales Channel, By Region, 2018-2025 (USD Million)
Table 5 Digital Therapeutics Market For Payers, By Region, 2018-2025 (USD Million)
Table 6 Digital Therapeutics Market For Employers, By Region, 2018-2025 (USD Million)
Table 7 Digital Therapeutics Market For Pharmaceutical Companies, By Region, 2018-2025 (USD Million)
Table 8 Digital Therapeutics Market For Providers, By Region, 2018-2025 (USD Million)
Table 9 Digital Therapeutics Market For Other Buyers, By Region, 018-2025 (USD Million)
Table 10 Digital Therapeutics Market For B2C Sales Channel, By Buyer, 2018-2025 (USD Million)
Table 11 Digital Therapeutics Market For B2C Sales Channel, By Region, 2018-2025 (USD Million)
Table 12 Digital Therapeutics Market For Caregivers, By Region, 2018-2025 (USD Million)
Table 13 Digital Therapeutics Market For Patients, By Region, 2018-2025 (USD Million)
Table 14 Digital Therapeutics Market, By Application, 2018-2025 (USD Million)
Table 15 Digital Therapeutics Market For Treatment/Care-Related Applications, By Type, 2018-2025 (USD Million)
Table 16 Digital Therapeutics Market For Treatment/Care-Related Applications, By Region, 2018-2025 (USD Million)
Table 17 Digital Therapeutics Market For Diabetes, By Region, 2018-2025 (USD Million)
Table 18 Digital Therapeutics Market For Cns Disorders, By Region, 2018-2025 (USD Million)
Table 19 Digital Therapeutics Market For Smoking Cessation, By Region, 2018-2025 (USD Million)
Table 20 Digital Therapeutics Market For Chronic Respiratory Diseases, By Region, 2018-2025 (USD Million)
Table 21 Digital Therapeutics Market For Musculoskeletal Disorders, By Region, 2018-2025 (USD Million)
Table 22 Digital Therapeutics Market For Cardiovascular Diseases, By Region, 2018-2025 (USD Million)
Table 23 Digital Therapeutics Market For Medication Adherence, By Region, 2018-2025 (USD Million)
Table 24 Digital Therapeutics Market For Gastrointestinal Disorders, By Region, 2018-2025 (USD Million)
Table 25 Digital Therapeutics Market For Rehabilitation & Patient Care, By Region, 2018-2025 (USD Million)
Table 26 Digital Therapeutics Market For Substance Use Disorders & Addiction Management, By Region, 2018-2025 (USD Million)
Table 27 Digital Therapeutics Market For Other Treatment/Care-Related Applications, By Region, 2018-2025 (USD Million)
Table 28 Digital Therapeutics Market For Preventive Applications, By Type, 2018-2025 (USD Million)
Table 29 Digital Therapeutics Market For Preventive Applications, By Region, 2018-2025 (USD Million)
Table 30 Digital Therapeutics Market For Prediabetes, By Region, 2018-2025 (USD Million)
Table 31 Digital Therapeutics Market For Obesity, By Region, 2018-2025 (USD Million)
Table 32 Digital Therapeutics Market For Nutrition, By Region, 2018-2025 (USD Million)
Table 33 Digital Therapeutics Market For Lifestyle Management, By Region, 2018-2025 (USD Million)
Table 34 Digital Therapeutics Market For Other Preventive Applications, By Region, 2018-2025 (USD Million)
Table 35 Digital Therapeutics Market, By Region, 2018-2025 (USD Million)
Table 36 North America: Digital Therapeutics Market, By Country, 2018-2025 (USD Million)
Table 37 North America: Digital Therapeutics Market, By Application, 2018-2025 (USD Million)
Table 38 North America: Digital Therapeutics Market For Treatment/Care-Based Applications, By Type, 2018-2025 (USD Million)
Table 39 North America: Digital Therapeutics Market For Preventive Applications, By Type, 2018-2025 (USD Million)
Table 40 North America: Digital Therapeutics Market, By Sales Channel, 2018-2025 (USD Million)
Table 41 North America: Digital Therapeutics Market For B2C Sales Channel, By Buyer, 2018-2025 (USD Million)
Table 42 North America: Digital Therapeutics Market For B2B Sales Channel, By Buyer, 2018-2025 (USD Million)
Table 43 Us: Digital Therapeutics Market, By Application, 2018-2025 (USD Million)
Table 44 Us: Digital Therapeutics Market For Treatment/Care-Based Applications, By Type, 2018-2025 (USD Million)
Table 45 Us: Digital Therapeutics Market For Preventive Applications, By Type, 2018-2025 (USD Million)
Table 46 Us: Digital Therapeutics Market, By Sales Channel, 2018-2025 (USD Million)
Table 47 Us: Digital Therapeutics Market For B2C Sales Channel, By Buyer, 2018-2025 (USD Million)
Table 48 Us: Digital Therapeutics Market For B2B Sales Channel, By Buyer, 2018-2025 (USD Million)
Table 49 Canada: Digital Therapeutics Market, By Application, 2018-2025 (USD Million)
Table 50 Canada: Digital Therapeutics Market For Treatment/Care-Based Applications, By Type, 2018-2025 (USD Million)
Table 51 Canada: Digital Therapeutics Market For Preventive Applications, By Type, 2018-2025 (USD Million)
Table 52 Canada: Digital Therapeutics Market, By Sales Channel, 2018-2025 (USD Million)
Table 53 Canada: Digital Therapeutics Market For B2C Sales Channel, By Buyer, 2018-2025 (USD Million)
Table 54 Canada: Digital Therapeutics Market For B2B Sales Channel, By Buyer, 2018-2025 (USD Million)
Table 55 Europe: Digital Therapeutics Market, By Country, 2018-2025 (USD Million)
Table 56 Europe: Digital Therapeutics Market, By Application, 2018-2025 (USD Million)
Table 57 Europe: Digital Therapeutics Market For Treatment/Care-Based Applications, By Type, 2018-2025 (USD Million)
Table 58 Europe: Digital Therapeutics Market For Preventive Applications, By Type, 2018-2025 (USD Million)
Table 59 Europe: Digital Therapeutics Market, By Sales Channel, 2018-2025 (USD Million)
Table 60 Europe: Digital Therapeutics Market For B2C Sales Channel, By Buyer, 2018-2025 (USD Million)
Table 61 Europe: Digital Therapeutics Market For B2B Sales Channel, By Buyer, 2018-2025 (USD Million)
Table 62 Germany: Digital Therapeutics Market, By Application, 2018-2025 (USD Million)
Table 63 Germany: Digital Therapeutics Market For Treatment/Care-Based Applications, By Type, 2018-2025 (USD Million)
Table 64 Germany: Digital Therapeutics Market For Preventive Applications, By Type, 2018-2025 (USD Million)
Table 65 Germany: Digital Therapeutics Market, By Sales Channel, 2018-2025 (USD Million)
Table 66 Germany: Digital Therapeutics Market For B2C Sales Channel, By Buyer, 2018-2025 (USD Million)
Table 67 Germany: Digital Therapeutics Market For B2B Sales Channel, By Buyer, 2018-2025 (USD Million)
Table 68 Uk: Digital Therapeutics Market, By Application, 2018-2025 (USD Million)
Table 69 Uk: Digital Therapeutics Market For Treatment/Care-Based Applications, By Type, 2018-2025 (USD Million)
Table 70 Uk: Digital Therapeutics Market For Preventive Applications, By Type, 2018-2025 (USD Million)
Table 71 Uk: Digital Therapeutics Market, By Sales Channel, 2018-2025 (USD Million)
Table 72 Uk: Digital Therapeutics Market For B2C Sales Channel, By Buyer, 2018-2025 (USD Million)
Table 73 Uk: Digital Therapeutics Market For B2B Sales Channel, By Buyer, 2018-2025 (USD Million)
Table 74 France: Digital Therapeutics Market, By Application, 2018-2025 (USD Million)
Table 75 France: Digital Therapeutics Market For Treatment/Care-Based Applications, By Type, 2018-2025 (USD Million)
Table 76 France: Digital Therapeutics Market For Preventive Applications, By Type, 2018-2025 (USD Million)
Table 77 France: Digital Therapeutics Market, By Sales Channel, 2018-2025 (USD Million)
Table 78 France: Digital Therapeutics Market For B2C Sales Channel, By Buyer, 2018-2025 (USD Million)
Table 79 France: Digital Therapeutics Market For B2B Sales Channel, By Buyer, 2018-2025 (USD Million)
Table 80 Spain: Digital Therapeutics Market, By Application, 2018-2025 (USD Million)
Table 81 Spain: Digital Therapeutics Market For Treatment/Care-Based Applications, By Type, 2018-2025 (USD Million)
Table 82 Spain: Digital Therapeutics Market For Preventive Applications, By Type, 2018-2025 (USD Million)
Table 83 Spain: Digital Therapeutics Market, By Sales Channel, 2018-2025 (USD Million)
Table 84 Spain: Digital Therapeutics Market For B2C Sales Channel, By Buyer, 2018-2025 (USD Million)
Table 85 Spain: Digital Therapeutics Market For B2B Sales Channel, By Buyer, 2018-2025 (USD Million)
Table 86 Italy: Digital Therapeutics Market, By Application, 2018-2025 (USD Million)
Table 87 Italy: Digital Therapeutics Market For Treatment/Care-Based Applications, By Type, 2018-2025 (USD Million)
Table 88 Italy: Digital Therapeutics Market For Preventive Applications, By Type, 2018-2025 (USD Million)
Table 89 Italy: Digital Therapeutics Market, By Sales Channel, 2018-2025 (USD Million)
Table 90 Italy: Digital Therapeutics Market For B2C Sales Channel, By Buyer, 2018-2025 (USD Million)
Table 91 Italy: Digital Therapeutics Market For B2B Sales Channel, By Buyer, 2018-2025 (USD Million)
Table 92 Roe: Digital Therapeutics Market, By Application, 2018-2025 (USD Million)
Table 93 Roe: Digital Therapeutics Market For Treatment/Care-Based Applications, By Type, 2018-2025 (USD Million)
Table 94 Roe: Digital Therapeutics Market For Preventive Applications, By Type, 2018-2025 (USD Million)
Table 95 Roe: Digital Therapeutics Market, By Sales Channel, 2018-2025 (USD Million)
Table 96 Roe: Digital Therapeutics Market For B2C Sales Channel, By Buyer, 2018-2025 (USD Million)
Table 97 Roe: Digital Therapeutics Market For B2B Sales Channel, By Buyer, 2018-2025 (USD Million)
Table 98 Apac: Digital Therapeutics Market, By Country, 2018-2025 (USD Million)
Table 99 Apac: Digital Therapeutics Market, By Application, 2018-2025 (USD Million)
Table 100 Apac: Digital Therapeutics Market For Treatment/Care-Based Applications, By Type, 2018-2025 (USD Million)
Table 101 Apac: Digital Therapeutics Market For Preventive Applications, By Type, 2018-2025 (USD Million)
Table 102 Apac: Digital Therapeutics Market, By Sales Channel, 2018-2025 (USD Million)
Table 103 Apac: Digital Therapeutics Market For B2C Sales Channel, By Buyer, 2018-2025 (USD Million)
Table 104 Apac: Digital Therapeutics Market For B2B Sales Channel, By Buyer, 2018-2025 (USD Million)
Table 105 Japan: Digital Therapeutics Market, By Application, 2018-2025 (USD Million)
Table 106 Japan: Digital Therapeutics Market For Treatment/Care-Based Applications, By Type, 2018-2025 (USD Million)
Table 107 Japan: Digital Therapeutics Market For Preventive Applications, By Type, 2018-2025 (USD Million)
Table 108 Japan: Digital Therapeutics Market, By Sales Channel, 2018-2025 (USD Million)
Table 109 Japan: Digital Therapeutics Market For B2C Sales Channel, By Buyer, 2018-2025 (USD Million)
Table 110 Japan: Digital Therapeutics Market For B2B Sales Channel, By Buyer, 2018-2025 (USD Million)
Table 111 China: Digital Therapeutics Market, By Application, 2018-2025 (USD Million)
Table 112 China: Digital Therapeutics Market For Treatment/Care-Based Applications, By Type, 2018-2025 (USD Million)
Table 113 China: Digital Therapeutics Market For Preventive Applications, By Type, 2018-2025 (USD Million)
Table 114 China: Digital Therapeutics Market, By Sales Channel, 2018-2025 (USD Million)
Table 115 China: Digital Therapeutics Market For B2C Sales Channel, By Buyer, 2018-2025 (USD Million)
Table 116 China: Digital Therapeutics Market For B2B Sales Channel, By Buyer, 2018-2025 (USD Million)
Table 117 India: Digital Therapeutics Market, By Application, 2018-2025 (USD Million)
Table 118 India: Digital Therapeutics Market For Treatment/Care-Based Applications, By Type, 2018-2025 (USD Million)
Table 119 India: Digital Therapeutics Market For Preventive Applications, By Type, 2018-2025 (USD Million)
Table 120 India: Digital Therapeutics Market, By Sales Channel, 2018-2025 (USD Million)
Table 121 India: Digital Therapeutics Market For B2C Sales Channel, By Buyer, 2018-2025 (USD Million)
Table 122 India: Digital Therapeutics Market For B2B Sales Channel, By Buyer, 2018-2025 (USD Million)
Table 123 Roapac: Digital Therapeutics Market, By Application, 2018-2025 (USD Million)
Table 124 Roapac: Digital Therapeutics Market For Treatment/Care-Based Applications, By Type, 2018-2025 (USD Million)
Table 125 Roapac: Digital Therapeutics Market For Preventive Applications, By Type, 2018-2025 (USD Million)
Table 126 Roapac: Digital Therapeutics Market, By Sales Channel, 2018-2025 (USD Million)
Table 127 Roapac: Digital Therapeutics Market For B2C Sales Channel, By Buyer, 2018-2025 (USD Million)
Table 128 Roapac: Digital Therapeutics Market For B2B Sales Channel, By Buyer, 2018-2025 (USD Million)
Table 129 Row: Digital Therapeutics Market, By Application, 2018-2025 (USD Million)
Table 130 Row: Digital Therapeutics Market For Treatment/Care-Based Applications, By Type, 2018-2025 (USD Million)
Table 131 Row: Digital Therapeutics Market For Preventive Applications, By Type, 2018-2025 (USD Million)
Table 132 Row: Digital Therapeutics Market, By Sales Channel, 2018-2025 (USD Million)
Table 133 Row: Digital Therapeutics Market For B2C Sales Channel, By Buyer, 2018-2025 (USD Million)
Table 134 Row: Digital Therapeutics Market For B2B Sales Channel, By Buyer, 2018-2025 (USD Million)

List of Figures

Figure 1 Research Design
Figure 2 Primary Sources
Figure 3 Breakdown Of Primary Interviews (Supply Side): By Company Type, Designation, And Region
Figure 4 Breakdown Of Primary Interviews (Demand Side): By Type Of Buyer And Region
Figure 5 Estimation Of The Digital Therapeutics Market: Revenue Mapping-Based Estimation
Figure 6 Market Size Estimation: Buyer Adoption-Based
Figure 7 Penetration Rate-Based Market Estimation
Figure 8 Data Triangulation Methodology
Figure 9 Digital Therapeutics Market, By Sales Channel, 2020 Vs. 2025 (USD Million)
Figure 10 Caregivers Segment To Register Significant Growth During The Forecast Period
Figure 11 Payers To Dominate The Digital Therapeutics Market During The Forecast Period
Figure 12 Digital Therapeutics Market, By Application (2020-2025)
Figure 13 Digital Therapeutics Market For Treatment/Care-Related Applications (2020-2025)
Figure 14 Geographical Snapshot Of The Digital Therapeutics Market
Figure 15 Increasing Incidence Of Chronic Diseases & Technological Advancements Are Driving The Adoption Of Digital Therapeutics
Figure 16 B2B Sales Dominate The Digital Therapeutics Market
Figure 17 Payers Held The Largest Share Of The Market, By B2B Sales Channel, In 2019
Figure 18 North America Is The Fastest-Growing Market For Digital Therapeutics
Figure 19 Digital Therapeutics Market: Drivers, Restraints, Opportunities, And Challenges
Figure 20 North America: Digital Therapeutics Market Snapshot
Figure 21 Europe: Digital Therapeutics Market Snapshot
Figure 22 Key Developments In The Digital Therapeutics Market
Figure 23 Digital Therapeutics Market Ranking Analysis, 2019
Figure 24 Digital Therapeutics (Dtx) Market (Global) Competitive Leadership Mapping